Positive Results for Supira Medical and Magenta Medical's Percutaneous Ventricular Assist Devices

Supira Medical and Magenta Medical have both received positive results from their respective studies on percutaneous ventricular assist devices. Supira Medical's Supira System received FDA breakthrough device designation and closed a $40M Series D financing round. Magenta Medical's Elevate System demonstrated the feasibility and safety of providing temporary mechanical circulatory support during high-risk PCI procedures.